US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

268.39

+7.092.71%

Pre-market: 264.33-4.0650-1.51%04:01 EDT

Volume:213.24K

Turnover:57.02M

Market Cap:529.93M

PE:- -

High:275.40

Open:264.98

Low:261.59

Close:261.30

52wk High:341.93

52wk Low:74.95

Shares:1.97M

Float Shares:1.97M

Volume Ratio:0.87

T/O Rate:10.80%

Dividend:1.02

Dividend Rate:0.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concord Healthcare Controlling Shareholder Revises H-Share Pledge for Smaller Loan

Definium Therapeutics Gains FDA Breakthrough for Depression Drug

CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Intellia Therapeutics announces FDA acceptance of lonvo-z BLA

Alebund Wins FDA IND Clearance for First-in-Class IgA Nephropathy Drug AP308

NovaBridge Biosciences Strengthens Board with Appointment of Veteran Healthcare Executive

Definium Therapeutics receives Breakthrough Therapy designation for DT120 ODT

Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

X4 Pharmaceuticals Announces Positive Outcome from FDA Type C Meeting

Analysts Offer Insights on Healthcare Companies: Dyne Therapeutics (DYN), NewAmsterdam Pharma Company (NAMS) and Ionis Pharmaceuticals (IONS)

Apitegromab’s Expanding FSHD Opportunity Supports Buy Rating; $65 Price Target Maintained

TEDA BIOMEDICAL Joins Forces with Xingchen Universal to Accelerate Embodied AI in Healthcare

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Royalty Pharma (RPRX) and Summit Therapeutics (SMMT)

Guardant Health's Breast Cancer Diagnostic Approved by US FDA

MT Newswires Live

Wall Street Analysts Are Bullish on Top Healthcare Picks

Guardant Health: FDA Companion Dx Approval for Camizestrant Validates Longitudinal Liquid Biopsy and Supports Buy Rating

Health Care Roundup: Market Talk

Echo IQ faces FDA setback on EchoSolv HF but leans on strong cash and approved platform

Barclays Remains a Buy on Spire Healthcare (SPI)

Inspiration Healthcare posts strong underlying growth as neonatal portfolio drives outlook ahead of forecasts

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/LABU/news?page=11"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":268.39,"timestamp":1789416000000,"preClose":261.3,"halted":0,"volume":213240,"hourTrading":{"tag":"盘前","latestPrice":264.325,"preClose":268.39,"latestTime":"04:01 EDT","volume":175,"amount":46695.9465,"timestamp":1789459265151,"change":-4.065,"changeRate":-0.015146,"amplitude":0.021145},"delay":0,"changeRate":0.02713356295445838,"floatShares":1974486,"shares":1974486,"eps":0,"marketStatus":"Pre-Mkt","change":7.09,"latestTime":"09-15 04:01:09 EDT","open":264.98,"high":275.4,"low":261.59,"amount":57016559.00399999,"amplitude":0.052851,"askPrice":269.6,"askSize":200,"bidPrice":262,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789479000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":268.39,"sharesOutstanding":3074486,"nav":261.603,"aum":516531253.77,"dividendRate":0.003797,"bidAskSpread":0.003144,"preHourTrading":{"tag":"盘前","latestPrice":264.325,"preClose":268.39,"latestTime":"04:01 EDT","volume":175,"amount":46695.9465,"timestamp":1789459265151,"change":-4.065,"changeRate":-0.015146,"amplitude":0.021145},"postHourTrading":{"tag":"盘后","latestPrice":269.01,"preClose":268.39,"latestTime":"19:59 EDT","volume":1202,"amount":323474.0356,"timestamp":1789430373217,"change":0.62,"changeRate":0.00231,"amplitude":0.004147},"volumeRatio":0.869032,"impliedVol":0.9094,"impliedVolPercentile":0.496},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1974486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.869032,"shares":1974486,"dividePrice":1.0191,"high":275.4,"amplitude":0.052851,"preClose":261.3,"low":261.59,"week52Low":74.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":268.39,"eps":0,"divideRate":0.003797,"volume":213240,"delay":0,"ttmEps":0,"open":264.98,"prevYearClose":159.39,"prevWeekClose":261.3,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":303.55,"twentyDayClose":276.54,"sixtyDayClose":200.41},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:11,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665378258","title":"Concord Healthcare Controlling Shareholder Revises H-Share Pledge for Smaller Loan","url":"https://stock-news.laohu8.com/highlight/detail?id=2665378258","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665378258?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:37","pubTimestamp":1788871052,"startTime":"0","endTime":"0","summary":"Concord Healthcare Group Co., Ltd. Class H ( ($HK:2453) ) just unveiled an announcement. Concord Healthcare Group Co., Ltd. has disclosed that its ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/concord-healthcare-controlling-shareholder-revises-h-share-pledge-for-smaller-loan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/concord-healthcare-controlling-shareholder-revises-h-share-pledge-for-smaller-loan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XBI","CNDA","BK4588","LU0029874061.USD","BK4581","LU0128526141.USD","XLV","BK4137","HCSG","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665937815","title":"Definium Therapeutics Gains FDA Breakthrough for Depression Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2665937815","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665937815?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:35","pubTimestamp":1788870934,"startTime":"0","endTime":"0","summary":"Definium Therapeutics ( ($DFTX) ) just unveiled an announcement. On September 8, 2026, Definium Therapeutics announced that the U.S. Food and Drug ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-gains-fda-breakthrough-for-depression-drug?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-gains-fda-breakthrough-for-depression-drug?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU","BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665378198","title":"CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2665378198","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665378198?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:30","pubTimestamp":1788870600,"startTime":"0","endTime":"0","summary":"ZUG, Switzerland and BOSTON, Sept.  08, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will present at the Morgan Stanley 24th A","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357662/0/en/crispr-therapeutics-to-present-at-the-morgan-stanley-24th-annual-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","LU0128526141.USD","BK4588","BK4137","LU1861558580.USD","LABU","XBI","BK4581","LU0029874061.USD","LU1861559042.SGD","SYNB","BK4585","BK4611","HCSG","XLV","ARKG","CRSP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665320747","title":"Intellia Therapeutics announces FDA acceptance of lonvo-z BLA","url":"https://stock-news.laohu8.com/highlight/detail?id=2665320747","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665320747?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:11","pubTimestamp":1788869463,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics (NTLA) announced the FDA has accepted the biologics license application for lonvo-z and granted the BLA Priority Review with ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/intellia-therapeutics-announces-fda-acceptance-of-lonvo-z-bla-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/intellia-therapeutics-announces-fda-acceptance-of-lonvo-z-bla-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861558580.USD","BK4585","BK4588","BK4535","BK4139","LABU","LU1861559042.SGD","BK4556","NTLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665320061","title":"Alebund Wins FDA IND Clearance for First-in-Class IgA Nephropathy Drug AP308","url":"https://stock-news.laohu8.com/highlight/detail?id=2665320061","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665320061?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:07","pubTimestamp":1788869273,"startTime":"0","endTime":"0","summary":"Alebund Pharmaceuticals (Jiangsu) Limited Class H ( ($HK:9637) ) has shared an update. Alebund Pharmaceuticals has secured clearance from the U.S. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alebund-wins-fda-ind-clearance-for-first-in-class-iga-nephropathy-drug-ap308?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alebund-wins-fda-ind-clearance-for-first-in-class-iga-nephropathy-drug-ap308?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327109","title":"NovaBridge Biosciences Strengthens Board with Appointment of Veteran Healthcare Executive","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327109","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327109?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:28","pubTimestamp":1788866923,"startTime":"0","endTime":"0","summary":"The latest announcement is out from NovaBridge Biosciences ( ($NBP) ). NovaBridge Biosciences reported on September 8, 2026, that it has appointed ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novabridge-biosciences-strengthens-board-with-appointment-of-veteran-healthcare-executive?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novabridge-biosciences-strengthens-board-with-appointment-of-veteran-healthcare-executive?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","XLV","LU0029874061.USD","BK4585","LU0128526141.USD","BK4137","LABU","XBI","NBP","HCSG","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665387327","title":"Definium Therapeutics receives Breakthrough Therapy designation for DT120 ODT","url":"https://stock-news.laohu8.com/highlight/detail?id=2665387327","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665387327?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:11","pubTimestamp":1788865879,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) announced that the U.S. Food and Drug Administration, FDA, has granted Breakthrough Therapy designation for DT120 Oral...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-receives-breakthrough-therapy-designation-for-dt120-odt-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-receives-breakthrough-therapy-designation-for-dt120-odt-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4585","LABU","ODT","DFTX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665716322","title":"Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2665716322","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665716322?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:00","pubTimestamp":1788865200,"startTime":"0","endTime":"0","summary":"BOSTON, Sept.  08, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of ora","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357480/0/en/atea-pharmaceuticals-to-present-at-the-morgan-stanley-24th-annual-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU0029874061.USD","BK4588","LU0128526141.USD","XBI","XLV","LABU","AVIR","BK4137","BK4007","BK4585","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322718","title":"X4 Pharmaceuticals Announces Positive Outcome from FDA Type C Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322718","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322718?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:00","pubTimestamp":1788865200,"startTime":"0","endTime":"0","summary":"- FDA Agrees to Reduced Sample Size for the Global 4WARD Phase 3 Chronic Neutropenia Trial - - Expect Completion of Enrollment by Year-End 2026 and Topline Data in H1 2028 - BOSTON, Sept.  08, 2026 (G","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357473/0/en/x4-pharmaceuticals-announces-positive-outcome-from-fda-type-c-meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665232230","title":"Analysts Offer Insights on Healthcare Companies: Dyne Therapeutics (DYN), NewAmsterdam Pharma Company (NAMS) and Ionis Pharmaceuticals (IONS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665232230","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665232230?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:50","pubTimestamp":1788864614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Dyne Therapeutics (DYN), NewAmsterdam Pharma Company...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dyne-therapeutics-dyn-newamsterdam-pharma-company-nams-and-ionis-pharmaceuticals-ions-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dyne-therapeutics-dyn-newamsterdam-pharma-company-nams-and-ionis-pharmaceuticals-ions-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DYN","IONS","NAMS","XLV","BK4585","HCSG","LU0128526141.USD","BK4581","BK4137","LU0029874061.USD","BK4139","BK4588","XBI","LABU","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322379","title":"Apitegromab’s Expanding FSHD Opportunity Supports Buy Rating; $65 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322379","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322379?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:45","pubTimestamp":1788864320,"startTime":"0","endTime":"0","summary":"Scholar Rock Holding, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Andres Y. Maldonado from H.C. Wainwright...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/apitegromabs-expanding-fshd-opportunity-supports-buy-rating-65-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/apitegromabs-expanding-fshd-opportunity-supports-buy-rating-65-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","XLV","BK4581","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194569723","title":"TEDA BIOMEDICAL Joins Forces with Xingchen Universal to Accelerate Embodied AI in Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=1194569723","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194569723?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:42","pubTimestamp":1788864140,"startTime":"0","endTime":"0","summary":"TEDA BIOMEDICAL (08189) has announced the signing of a strategic cooperation framework agreement with Hunan Xingchen Universal Robot Co., Ltd. (referred to as \"Xingchen Universal\").Under the terms of...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","08189","BK1113","BK4588","XLV","WDRN","BK4550","BK4581","159760","VHT","LABU","IXJ","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665232106","title":"Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Royalty Pharma (RPRX) and Summit Therapeutics (SMMT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665232106","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665232106?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:10","pubTimestamp":1788862214,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AbbVie (ABBV), Royalty Pharma (RPRX) and Summit Ther...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbvie-abbv-royalty-pharma-rprx-and-summit-therapeutics-smmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbvie-abbv-royalty-pharma-rprx-and-summit-therapeutics-smmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1929549753.HKD","IXJ","LU0128525929.USD","PJP","LU0861579265.USD","FHLC","IYH","LU0859254822.USD","LU1291159041.SGD","IE00B3PB1722.GBP","AGNG","FTXH","BK4550","LU0965509010.AUD","RXL","BK4137","HCSG","IE00BVYPNV92.GBP","MEDX","LU1551013342.USD","LU0211328371.USD","SMMT","JDOC","LU0211327993.USD","XBI","LU1037948897.HKD","ABBV","LU0553294199.USD","LU2237443549.SGD","VHT","TRUH","LU0417517546.SGD","IE0004445239.USD","LU0029874061.USD","LU2433249047.HKD","RPRX","LABU","IE000BZT7R73.USD","LU1057294990.SGD","PPH","LU1244550494.USD","LU1003077747.HKD","GLAM","IHE","XLV","LU0823416689.USD","LU0689626769.HKD","LU2347655073.USD","PBE","LU2125909247.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665321994","title":"Guardant Health's Breast Cancer Diagnostic Approved by US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2665321994","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665321994?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:08","pubTimestamp":1788862114,"startTime":"0","endTime":"0","summary":"Guardant Health's  Guardant360 CDx has been approved by the US Food and Drug Administration as a companion diagnostic for advanced metastatic breast cancer, the company said Friday.The specific indication for the diagnostic combination is to identify patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer harboring tumors with specific mutations before radiographic progression who may benefit from treatment with AstraZeneca's  Etcamah, the company said.The approval is based on data from a clinical trial showing a 56% reduction in the risk of progression or death, the company said.Shares of the company were up 1% in recent premarket trading.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2237443895.HKD","AZN","HELX","LU2456880835.USD","LU2462157665.USD","LU0708994859.HKD","AZNH","LU0109394709.USD","LU0289739699.SGD","LU2468319806.SGD","GH","LU0128525929.USD","LU2089984988.USD","LABU","LU2236285917.USD","LU0310800379.SGD","EKG","LU1267930573.SGD","GDOC","LU0320765992.SGD","LU0029864427.USD","FFOX","GNMX","LFSC","LU2237443622.USD","PTH","BK4551","BK4585","LU0432979614.USD","BK4568","LU2237443978.SGD","GNOM","LU0889565916.HKD","LU2417539215.USD","LU1829250122.USD","LU0058720904.USD","BK4007","LU2237443549.SGD","BK4535","BK4196","LU2237443465.HKD","LU2237443382.USD","IE00B3T34201.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665329053","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2665329053","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665329053?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:50","pubTimestamp":1788861008,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Boston Scientific (BSX) and Neurosense Therapeutics ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-330?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-330?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2244417387.USD","LU2357305700.SGD","SG9999001176.SGD","LU2324357040.USD","HCSG","IE00BJJMRZ35.SGD","LU2362541513.USD","LU1291159041.SGD","LU1057294990.SGD","LU1720051108.HKD","BK4588","BSX","LU0345769128.USD","LU2506952097.USD","LABU","LU1804176565.USD","LU0225283273.USD","LU0238689110.USD","LU1366192091.USD","LU0114720955.EUR","LU0029874061.USD","LU2112291526.USD","LU2491050154.USD","SG9999013999.USD","LU0823416689.USD","BK4581","LU0128526141.USD","LU1989764664.SGD","LU0882574055.USD","LU0950375773.USD","LU0345769631.USD","LU1791710582.SGD","LU0353189763.USD","LU0251132253.USD","LU0187121727.USD","LU0138981039.USD","LU0048584097.USD","LU2362541273.HKD","LU2506951875.HKD","SG9999001176.USD","BK4504","LU0432979614.USD","XLV","LU1023059063.AUD","LU2491050071.SGD","XBI","LU1989771016.USD","LU1720051017.SGD","BK4082","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665715325","title":"Guardant Health: FDA Companion Dx Approval for Camizestrant Validates Longitudinal Liquid Biopsy and Supports Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2665715325","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665715325?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:45","pubTimestamp":1788857123,"startTime":"0","endTime":"0","summary":"William Blair analyst Matt Larew has maintained their bullish stance on GH stock, giving a Buy rating on September 1. Matt Larew has given his Buy ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/guardant-health-fda-companion-dx-approval-for-camizestrant-validates-longitudinal-liquid-biopsy-and-supports-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/guardant-health-fda-companion-dx-approval-for-camizestrant-validates-longitudinal-liquid-biopsy-and-supports-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665722323","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2665722323","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665722323?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:20","pubTimestamp":1788855600,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0817 GMT - Novartis's latest clinical-trial failure suggests the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4581","BK4585","BK4588","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665328838","title":"Echo IQ faces FDA setback on EchoSolv HF but leans on strong cash and approved platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2665328838","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665328838?lang=en_us&edition=fundamental","pubTime":"2026-09-08 15:07","pubTimestamp":1788851247,"startTime":"0","endTime":"0","summary":"EchoIQ Limited ( ($AU:EIQ) ) has provided an update. Echo IQ has received a Not Substantially Equivalent determination from the U.S. Food and Drug ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/echo-iq-faces-fda-setback-on-echosolv-hf-but-leans-on-strong-cash-and-approved-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/echo-iq-faces-fda-setback-on-echosolv-hf-but-leans-on-strong-cash-and-approved-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4552","IQ","BK4505","BK4531","BK4585","LABU","BK4526","BK4588","BK4108"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665408343","title":"Barclays Remains a Buy on Spire Healthcare (SPI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665408343","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665408343?lang=en_us&edition=fundamental","pubTime":"2026-09-08 14:36","pubTimestamp":1788849372,"startTime":"0","endTime":"0","summary":"Barclays analyst Hassan Al-Wakeel maintained a Buy rating on Spire Healthcare today and set a price target of £2.75. According to TipRanks, Al-Wake...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-buy-on-spire-healthcare-spi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-buy-on-spire-healthcare-spi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","HCSG","BK4137","XLV","LU0128526141.USD","XBI","LABU","BK4581","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665347169","title":"Inspiration Healthcare posts strong underlying growth as neonatal portfolio drives outlook ahead of forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=2665347169","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665347169?lang=en_us&edition=fundamental","pubTime":"2026-09-08 14:13","pubTimestamp":1788848017,"startTime":"0","endTime":"0","summary":"Inspiration Healthcare ( ($GB:IHC) ) has shared an announcement. Inspiration Healthcare reported revenue of £22.0 million for the six months to 31 ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inspiration-healthcare-posts-strong-underlying-growth-as-neonatal-portfolio-drives-outlook-ahead-of-forecasts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inspiration-healthcare-posts-strong-underlying-growth-as-neonatal-portfolio-drives-outlook-ahead-of-forecasts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4137","HCSG","BK4581","XBI","XLV","LABU","BK4585","LU0029874061.USD","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":11,"totalSize":420,"code":"91000000","status":"200"}]}}